Healthcare - Biotechnology - NASDAQ - US
$ 2.31
-4.55 %
$ 136 M
Market Cap
-1.78
P/E
BALANCE SHEET
436 M
ASSETS
39.4 M
LIABILITIES
397 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Seer, Inc.
| Current Assets | 331 M |
| Cash & Short-Term Investments | 316 M |
| Receivables | 6.72 M |
| Other Current Assets | 7.57 M |
| Non-Current Assets | 106 M |
| Long-Term Investments | 56.9 M |
| PP&E | 47.4 M |
| Other Non-Current Assets | 1.53 M |
| Current Liabilities | 13.2 M |
| Accounts Payable | 1.37 M |
| Short-Term Debt | 4.59 M |
| Other Current Liabilities | 7.26 M |
| Non-Current Liabilities | 26.1 M |
| Long-Term Debt | 26 M |
| Other Non-Current Liabilities | 179 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 32.5 | 53.2 | 232.8 | 333.6 | 17.5 | 31.0 |
| Short Term Investments | 283.7 | 368.0 | 167.3 | 98.3 | 68.5 | 0 |
| Receivables | 6.7 | 7.0 | 4.1 | 0.3 | 0.3 | 69 K |
| Inventory | 4.5 | 4.6 | 4.1 | 0.6 | 0 | 0 |
| Other Current Assets | 3.1 | 2.1 | 3.3 | 0.5 | 0.5 | 0.2 |
| Total Current Assets | 330.5 | 435.0 | 411.7 | 433.1 | 86.8 | 31.2 |
| PP&E | 47.4 | 46.4 | 33.2 | 8.4 | 5.7 | 2.4 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 56.9 | 5.2 | 93.2 | 0.3 | 0.3 | 0 |
| Other Long Term Assets | 1.5 | 1.4 | 1.0 | 0.4 | 0.4 | 0.1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 436.3 | 487.9 | 539.1 | 442.3 | 93.2 | 33.7 |
| LIABILITIES | ||||||
| Accounts Payable | 1.4 | 2.1 | 3.8 | 2.1 | 0.7 | 2.6 |
| Short Term Debt | 4.6 | 3.7 | 1.7 | 0 | 0 | 0 |
| Other Current Liabilities | 6.6 | 6.3 | 7.1 | 5.7 | 2.9 | 1.1 |
| Total Current Liabilities | 13.2 | 12.6 | 13.4 | 8.1 | 3.8 | 3.7 |
| Long Term Debt | 26.0 | 28.0 | 22.5 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.2 | 0.3 | 0.3 | 2.6 | 1.7 | 30 K |
| Total Liabilities | 39.4 | 40.9 | 36.2 | 10.7 | 5.6 | 3.7 |
| EQUITY | ||||||
| Common Stock | 1 K | 1 K | 1 K | 1 K | 0 | 0 |
| Retained Earnings | (305.8) | (219.5) | (126.5) | (55.4) | (22.6) | (6.5) |
| Other Accumulative Comprehensive Income/Loss | (0.2) | (1.3) | (0.5) | 54 K | 24 K | 31 K |
| Total Equity | 396.9 | 447.0 | 502.9 | 431.6 | 87.7 | 30.0 |
| Total Liabilities and Equity | 436.3 | 487.9 | 539.1 | 442.3 | 93.2 | 33.7 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 63.9 | 62.4 | 60.9 | 60.9 | 60.9 | 21.5 |